SF3B1 Mutation Linked to Immune Response Changes | Insights from CRISPR Studies in Stem Cells

In this episode of SciBud, we dive into the fascinating world of bioimaging and genetic mutations with a focus on the SF3B1K700E variant, a mutation frequently observed in blood cancers like myelodysplastic syndromes (MDS). Host Maple takes us through groundbreaking research that utilized CRISPR technology to modify human embryonic stem cells, revealing that this mutation enhances gene expression tied to immune responses and blood cell formation. However, the implications are complex: while the mutation upregulates immune-related genes in stem cells, these same genes are typically downregulated in mature cancer cells. This juxtaposition prompts intriguing questions about the context-dependent effects of genetic mutations. Join us as we explore the methodology behind these findings, including precision RNA sequencing, and consider the exciting prospects for future cancer therapies aimed at targeting splicing-related diseases. Tune in for an engaging discussion that highlights the intricate connections between genetics and immune response, and what it all means for cancer research. Link to episode page with article citation: www.scibud.media/podcast/season/2025/episode/315